Literature DB >> 6343460

Increased plasma arginine vasopressin levels in patients with congestive heart failure.

S R Goldsmith, G S Francis, A W Cowley, T B Levine, J N Cohn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6343460     DOI： 10.1016/s0735-1097(83)80040-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  90 in total

1.  Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure.

Authors:  Lisa C Costello-Boerrigter; Guido Boerrigter; Alessandro Cataliotti; Gail J Harty; John C Burnett
Journal:  Circ Heart Fail       Date:  2010-02-22       Impact factor: 8.790

Review 2.  Role of paraventricular nucleus in mediating sympathetic outflow in heart failure.

Authors:  K P Patel
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

Review 3.  Neurohormonal modulation in heart failure of ischemic etiology: correlates with left ventricular remodeling.

Authors:  Roberto Latini; Serge Masson; Lidia Staszewsky; Simona Barlera
Journal:  Curr Heart Fail Rep       Date:  2006-12

4.  Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure.

Authors:  Rohit Ramchandra; Sally G Hood; Anna M D Watson; Andrew M Allen; Clive N May
Journal:  Hypertension       Date:  2012-02-06       Impact factor: 10.190

5.  A reduction in SK channels contributes to increased activity of hypothalamic magnocellular neurons during heart failure.

Authors:  Hildebrando C Ferreira-Neto; Vinicia C Biancardi; Javier E Stern
Journal:  J Physiol       Date:  2017-08-02       Impact factor: 5.182

6.  Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways.

Authors:  Kyle K Henderson; Kenneth L Byron
Journal:  J Appl Physiol (1985)       Date:  2007-01-04

Review 7.  Integration of renal sensory afferents at the level of the paraventricular nucleus dictating sympathetic outflow.

Authors:  Hong Zheng; Kaushik P Patel
Journal:  Auton Neurosci       Date:  2016-08-06       Impact factor: 3.145

8.  Changes of renal AQP2, ENaC, and NHE3 in experimentally induced heart failure: response to angiotensin II AT1 receptor blockade.

Authors:  Sophie C Lütken; Soo Wan Kim; Thomas Jonassen; David Marples; Mark A Knepper; Tae-Hwan Kwon; Jørgen Frøkiaer; Søren Nielsen
Journal:  Am J Physiol Renal Physiol       Date:  2009-09-23

9.  Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia.

Authors:  P Nicod; J Biollaz; B Waeber; J J Goy; R Polikar; J Schlapfer; M D Schaller; G A Turini; J Nussberger; K G Hofbauer
Journal:  Br Heart J       Date:  1986-11

Review 10.  Cardiorenal syndrome: pathophysiology and potential targets for clinical management.

Authors:  Parta Hatamizadeh; Gregg C Fonarow; Matthew J Budoff; Sirous Darabian; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.